Guillaume Berton

5PUBLICATIONS
22CO-AUTHORS
Haematological tumoursRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 27, 2026
Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patients.

|Mar 15, 2025
Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High-Risk MDS Treated With Nucleoside Analogs.

Erwann Collomb, Laurent Bourguignon, Antoine Tichadou

|Jan 06, 2025
Outcomes of Elderly Patients Admitted to the Intensive Care Unit for Newly Diagnosed Acute Myeloid Leukemia.

Guillaume Berton, Marie-Anne Hospital, Sylvain Garciaz

|Jun 28, 2024
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML.

Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis

|May 16, 2024
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.

Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis

Pageof 1

Frequent Collaborators

2 joint publications

Shai Shimony

2 joint publications

Brian Ball

1 joint publications

Jan Philipp Bewersdorf

1 joint publications

Vinod Pullarkat